What is careviso?
Founded in 2017 and headquartered in Falls Church, Virginia, careviso operates within the dynamic healthcare technology landscape. The company focuses on leveraging technology to address critical needs within the healthcare industry. Its strategic positioning suggests a commitment to innovation and efficiency in healthcare delivery and management. The recent major strategic investment indicates strong investor confidence in careviso's business model and future potential.
How much funding has careviso raised?
careviso has raised a total of $17M across 1 funding round:
Series B
$17M
Series B (2022): $17M with participation from Lytical Ventures and Ballast Point Ventures
Key Investors in careviso
Lytical Ventures
Lytical Ventures is a venture capital firm specializing in cybersecurity, data analytics, AI, and enterprise intelligence, focusing on early-stage companies crucial for enterprise survival.
Ballast Point Ventures
Ballast Point Ventures provides expansion capital to rapidly growing private companies, primarily in software, tech-enabled services, and healthcare, with a focus on the Southeast and Texas.
What's next for careviso?
With the recent influx of major strategic investment, careviso is poised for accelerated growth and market penetration. The company is likely to focus on scaling its operations, enhancing its technological offerings, and expanding its client base. This enterprise-level funding provides the necessary resources to pursue ambitious development goals and solidify its competitive advantage in the healthcare technology market. Future strategic partnerships and product innovations are anticipated as careviso continues its expansion.
See full careviso company page
